Evidence map›Paper›PMID 31519890›Full record

ArticleNature communications2019

Dynamic changes of muscle insulin sensitivity after metabolic surgery.

Sofiya Gancheva, Meriem Ouni, Tomas Jelenik, Chrysi Koliaki, Julia Szendroedi, Frederico G S Toledo, Daniel F Markgraf, Dominik H Pesta, Lucia Mastrototaro, Elisabetta De Filippo and 7 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 76 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Observational
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Metabolic memory: mechanisms and diseases.Signal transduction and targeted therapy · 2024
    Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 3 countries.

Sofiya Gancheva *Division of Endocrinology and Diabetology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany.
Meriem Ouni *German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany.ORCID http://orcid.org/0000-0002-7781-8463
Tomas JelenikInstitute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research, Heinrich Heine University, Düsseldorf, Germany.
Chrysi KoliakiDivision of Endocrinology and Diabetology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany.
Julia SzendroediDivision of Endocrinology and Diabetology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany.
Frederico G S ToledoDivision of Endocrinology and Metabolism, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Daniel F MarkgrafInstitute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research, Heinrich Heine University, Düsseldorf, Germany.ORCID http://orcid.org/0000-0002-2252-8442
Dominik H PestaInstitute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research, Heinrich Heine University, Düsseldorf, Germany.ORCID http://orcid.org/0000-0002-5089-3586
Lucia MastrototaroInstitute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research, Heinrich Heine University, Düsseldorf, Germany.
Elisabetta De FilippoInstitute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research, Heinrich Heine University, Düsseldorf, Germany.
Christian HerderDivision of Endocrinology and Diabetology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany.ORCID http://orcid.org/0000-0002-2050-093X
Markus JähnertGerman Center for Diabetes Research (DZD e.V.), Neuherberg, Germany.ORCID http://orcid.org/0000-0001-6459-7318
Jürgen WeissGerman Center for Diabetes Research (DZD e.V.), Neuherberg, Germany.
Klaus StrassburgerGerman Center for Diabetes Research (DZD e.V.), Neuherberg, Germany.ORCID http://orcid.org/0000-0002-6636-1373
Matthias SchlensakGeneral Surgery Department, Schön Clinics, Düsseldorf, Germany.
Annette Schürmann *German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany.ORCID http://orcid.org/0000-0002-4113-4377
Michael Roden *Division of Endocrinology and Diabetology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany. michael.roden@ddz.uni-duesseldorf.de.ORCID http://orcid.org/0000-0001-8200-6382
Deutsches Diabetes-Zentrum e.V. · DEUniversity General Hospital Attikon · GRUniversity of Pittsburgh · USUniversity of Potsdam · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The mechanisms underlying improved insulin sensitivity after surgically-induced weight loss are still unclear. We monitored skeletal muscle metabolism in obese individuals before and over 52 weeks after metabolic surgery. Initial weight loss occurs in parallel with a decrease in muscle oxidative capacity and respiratory control ratio. Persistent elevation of intramyocellular lipid intermediates, likely resulting from unrestrained adipose tissue lipolysis, accompanies the lack of rapid changes in insulin sensitivity. Simultaneously, alterations in skeletal muscle expression of genes involved in calcium/lipid metabolism and mitochondrial function associate with subsequent distinct DNA methylation patterns at 52 weeks after surgery. Thus, initial unfavorable metabolic changes including insulin resistance of adipose tissue and skeletal muscle precede epigenetic modifications of genes involved in muscle energy metabolism and the long-term improvement of insulin sensitivity.

Indexed as

Adipose TissueAdultDNA MethylationEpigenesis, GeneticFemaleGastric BypassHumansInsulin ResistanceLipid MetabolismMaleMiddle AgedMuscle, SkeletalObesity

Identifiers

PMID31519890
PMCPMC6744497
OpenAlexW2972650179

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.